Comment on “Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease”.

Related Articles

Comment on “Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease”.

Inflamm Bowel Dis. 2019 Apr 11;25(5):e59

Authors: Pauwels RWM, de Vries AC, van der Woude CJ

PMID: 31222304 [PubMed – in process]

PubMed Link: https://www.ncbi.nlm.nih.gov/pubmed/31222304?dopt=Abstract